NCT00807846

A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects

A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 201 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 2 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This Is A Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis

Conditions

• Arthritis, Juvenile Rheumatoid

Interventions

Type	Name	Description
DRUG	Celecoxib	Celecoxib 50 mg or 100 mg PO BID for 6 weeks
DRUG	Naproxen	Naproxen 7.5 mg/kg PO BID \[maximum of 500 mg BID\] for 6 weeks

Timeline

• Start date: 2009-09-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2008-12-12
• Last updated: 2021-02-02
• Results posted: 2015-11-11

Locations

39 sites across 10 countries: United States, Chile, Costa Rica, Peru, Philippines, Russia, Serbia, South Africa, Switzerland, Ukraine